Insights On Drug Development
-
How To Bring (Any) mRNA To Life: Simplifying Nucleic Acid Encapsulation
5/6/2024
New technologies for the encapsulation of nucleic acids, such as FDmiX, can potentially overcome limitations of currently available standard mixing technologies.
-
Advances In Applied Nanotechnology For Formulating Better ASDs And mAbs
5/1/2024
Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.
-
Methods for mRNA Poly(A) Sizing
4/26/2024
This study used Oxford Nanopore Technologies' Direct RNA Sequencing Kit and obtained successful sizing of poly(A) tail regions. The results are presented in a histogram and table format.
-
AAV Analytics: Key Considerations When Developing A Clinical Program
4/25/2024
Finding partners with the necessary skills to optimize AAV processes is crucial for minimizing risk. Explore key considerations for advancing your therapy from concept to commercialization.
-
The Critical Role Of Comparative Analytical Assessments
4/25/2024
Utilize our expert analytical testing services to unlock the potential of biosimilars and bring cost-effective treatments to market faster.
-
New Instrumentation Expands Sediment Velocity AUC’s Utility
4/24/2024
Purified adeno-associated viruses (AAVs) are prepared as a variety capsid species that must be characterized and quantified to ensure safety and efficacy.
-
Identify And Quantify AAV Fill States Using Analytical Centrifugation
4/24/2024
Purified AAVs are prepared as a variety capsid species. To ensure gene therapy safety and efficacy, it is crucial to characterize and quantify those species.
-
Navigating OSD Formulation Development And Leveraging CDMO Partnership
4/17/2024
Collaborating with an experienced CDMO can provide the expertise and facilities needed to navigate oral solid dose formulation complexities and ensure compliance with regulatory frameworks.
-
Outsourcing High Potent Oral Solid Dose Late-Stage Development: CDMO Insights
4/17/2024
View the webinar to discover outsourcing options for highly potent oral solid dose therapies, and learn how CDMOs can transfer, handle and deliver their product to clinic and to market.
-
Tips For Viral Vector Production
4/16/2024
Learn about how meticulous purification optimization can maximize recovery and impurity removal by leveraging scalable downstream technologies to meet regulatory and process economy requirements.